RETINITIS PIGMENTOSA (RP)

This study is testing a tiny electronic implant called PRIMA that is placed in the eye. It aims to restore some central vision for people who have lost it due to inherited retinal diseases like Stargardt disease and retinitis pigmentosa. The study will check if the implant is saf…

This is a very early study to check if a new gene therapy called UGX202 is safe for people with advanced retinitis pigmentosa (RP), a disease that causes severe vision loss. Six patients with very low vision will receive a single injection of the therapy into one eye and be monit…

This early-stage trial is testing a new injection called ZM-02 for people with advanced retinitis pigmentosa, an inherited eye disease that causes progressive vision loss and has no effective treatment. The study will check if the injection is safe and if it can help preserve vis…

This study is testing whether a new drug called NPI-001 can slow down vision loss in adults with Usher syndrome, a rare genetic condition that causes both hearing and vision problems. Over 24 months, 80 participants will take either NPI-001 or a placebo (inactive substance) twice…

This small pilot study is testing whether a safe, painless form of brain stimulation can temporarily improve how well adults with severe tunnel vision can get around. Participants will receive a brief session of either real or fake stimulation and then walk a course with obstacle…

This study aims to test a new type of eye scanner that can take wider pictures of the back of the eye. Researchers want to see if this device helps doctors better understand, diagnose, and monitor a wide range of eye diseases that affect vision, like macular degeneration and diab…

This study looks back at medical records and eye scans from up to 200 people with inherited retinal diseases, which cause progressive vision loss. Researchers aim to understand how these diseases naturally change over time and how a person's specific genetic cause relates to thei…